Fractyl Health (GUTS) Other Working Capital Changes (2023 - 2026)
Fractyl Health's (GUTS) quarterly Other Working Capital Changes came in at -$379000.0 in Q1 2026, down 27.18% YoY from -$520470.0 in Q1 2025, and down 6.76% on a QoQ basis from -$355000.0 in Q4 2025.
Fractyl Health (GUTS) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Other Working Capital Changes data on file, last reported at -$379000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 27.18% year-over-year to -$379000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 776.12% YoY) and the FY2025 annual result came in at -$1.3 million, down 216.39% from the prior year.
- Other Working Capital Changes slipped to -$379000.0 in Q1 2026, from -$355000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q4 2024 to a low of -$2.4 million in Q3 2025.
- A 4-year average of $30153.8 and a median of $133000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes jumped 878.85% — and 2025, when it sank 149.75%.
- Tracing GUTS's Other Working Capital Changes over 4 years: stood at $804000.0 in 2023, then tumbled by 134.33% to -$276000.0 in 2024, then slipped by 28.62% to -$355000.0 in 2025, then dropped by 6.76% to -$379000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$379000.0 (Q1 2026), -$355000.0 (Q4 2025), and -$318000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -391,000.00 |
| Jun 30, 2026 | -391,000.00 |
| Jun 30, 2026 | -391,000.00 |
| Mar 31, 2026 | -379,000.00 |
| Mar 31, 2026 | -379,000.00 |
| Mar 31, 2026 | -379,000.00 |
| Dec 31, 2025 | -355,000.00 |
| Dec 31, 2025 | -355,000.00 |
| Dec 31, 2025 | -355,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Dec 31, 2024 | -276,000.00 |
| Dec 31, 2024 | -276,000.00 |